PACB — Pacific Biosciences of California Share News
0.000.00%
Last trade - 00:00- $609.23m
- $1.02bn
- $160.01m
Pacific Biosciences of California, Inc. reports results for the quarter ended June 30 - Earnings Summary
Pacific Biosciences Q2 adj. loss bigger than estimates on margin pressure
Brief: Pacific Biosciences of California Q2 EPS USD -0.14
Pacific Biosciences of California Inc expected to post a loss of 13 cents a share - Earnings Preview
DNA sequencing systems co PacBio Q1 adjusted loss narrows
Brief: Pacific Biosciences of California Q1 EPS USD -0.03
Brief: Pacbio Announces The Appointment Of Chris Gibson To The Board Of Directors
Brief: Pacific Biosciences Of California Files For Mixed Shelf Size
Brief: Pacbio And Dnastack Launch First Global Federated Hifi Whole Genome Dataset To Accelerate Rare Disease Research
PacBio Q4 revenue rises 14% driven by strong consumable sales
Brief: Pacific Biosciences of California Q4 Adjusted Net Income USD -37.6 Million Vs. IBES Estimate USD -44.3 Million
PacBio Q3 revenue falls to $38.4 mln, EPS beats
Brief: Pacific Biosciences of California Q3 EPS USD -0.13
Pacific Biosciences of California Inc reports results for the quarter ended June 30 - Earnings Summary
PacBio reports smaller-than-expected loss in Q2
Pacific Biosciences of California Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene
Pacific Biosciences of California Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Pacific Biosciences of California Q1 Adjusted Gross Profit USD 15 Million